𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCN21 NUMBER NEEDED TO TREAT (NNT) ANALYSIS COMPARING BENEFITS OF LETROZOLE WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH NODE-POSITIVE BREAST CANCER

✍ Scribed by N Dhillon; S Kaura; G Dranitsaris; H Rugo

Book ID: 118611866
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 80 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)74273-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P347 Benefit of denosumab therapy in pat

P347 Benefit of denosumab therapy in patients with bone metastases from breast cancer: A number-needed-to-treat (NNT) analysis

✍ M. Martin; G. Steger; R. von Moos; A. Stopeck; R. de Boer; H. Bourgeois; K. Inou 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Cardiac safety analysis of the first sta

Cardiac safety analysis of the first stage of NSABP B-31, a randomized trial comparing the safety and efficacy of doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) to that of AC followed by paclitaxel plus trastuzumab (TH) in patients (pts) with operable, node-positive (N+), HER-2 overexpressing breast cancer (HER2+BC)

✍ C Geyer; J Bryant; E Romond; E Tan-Chiu; M Ewer; D Keefe; R Shannon; G Yothers; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 541 KB